Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Lawmakers Criticize FDA’s Lack Of Action Removing Toxic Heavy Metals from Baby Food FDA has fallen behind schedule on addressing toxic heavy metals in baby food, putting children at risk of serious health problems, including autism and ADHD January 31, 2023 Russell Maas Add Your Comments Federal lawmakers have issued a sharp rebuke to the FDA, indicating that regulators are failing to do enough to remove toxic metals from baby food products, which have been linked to an increased risk of autism and ADHD for children. In 2021, a U.S. Congressional report ignited a firestorm of concerns over dangerous levels of lead, arsenic, cadmium and mercury found in a number of different popular baby foods, and nearly two years later reports suggest that toxic metals in baby food remain a pervasive problem, with high levels still found in popular brands sold by Gerber, Plum Organics, Sprout, Walmart and others. This week, Senators Tammy Duckworth and Amy Klobuchar joined together with Representatives Raja Krishnamoorthi and Tony Cardenas to send a letter (PDF) to FDA Commissioner Robert Califf, urging the agency to move expeditiously to finalize guidance for the industry about levels of any heavy metals in baby foods that will be actionable. Harmful Effects of Heavy Metals in Baby Foods The letter points to the wide range of harmful effects heavy metals in baby food can have on children, especially during one of the most critical stages of development and growth. “As you know, arsenic, lead, cadmium and mercury, while present in many foods we eat, can be especially harmful to children,” according to the letter. “These toxic heavy metals have a range of negative effects on a child’s health, particularly on neurological development, and can result in behavioral disorders and lower academic achievement.” Manufacturers of products found to contain high levels of these heavy metals already face hundreds of toxic baby food lawsuits, involving allegations that children developed autism spectrum disorders (ASD), attention deficit hyperactivity disorders (ADHD) and other side effects. BABY FOOD LAWSUITS Was your child exposed to toxic baby food? Toxic baby food sold by Gerber, Beech-Nut and other manufacturers contain dangerous levels of heavy metals, which may be the cause of autism and severe ADHD for children. Learn More SEE IF YOU QUALIFY FOR COMPENSATION BABY FOOD LAWSUITS Was your child exposed to toxic baby food? Toxic baby food sold by Gerber, Beech-Nut and other manufacturers contain dangerous levels of heavy metals, which may be the cause of autism and severe ADHD for children. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The lawmakers indicate there are no safe blood levels for lead in children, as it is well documented that exposure can damage a child’s brain and nervous system, slow growth and development, and increase the risk of long-term health complications. Similar neurological effects are also known to occur from exposure to high levels of mercury, according to the letter. While the letter did thank the FDA for recently releasing new baby food lead limits last week, the Senators and Representatives indicate that more must be done to ensure the safety of foods consumed by babies and young children. FDA “Closer to Zero” Plan Shortly after the U.S. Congressional report was released in 2021, the FDA announced a “Closer to Zero” plan to remove heavy metals from baby food, indicating that the agency would assign a team of investigators to begin collecting and interpreting the existing science to determine what levels are both safe and achievable for lead, arsenic cadmium and mercury in baby food. While the agency stated back in early 2021 that it anticipated announcing the first proposed guidelines for lead in April 2022, the proposed guidance on lead was just released earlier this month, approximately nine months behind schedule. Officials also still must still finalize and issue a final rule for lead levels, and repeat the process for arsenic, cadmium and mercury. The lawmakers indicate the FDA needs to speed up its efforts, in order to protect children from potentially serious and life-threatening health risks. “It is deeply concerning that high levels of toxic heavy metals remain in our Nation’s manufactured baby foods,” the senators wrote. “Given the severity of the potential dangers posed by this, we urge FDA to expeditiously finalize guidance documents for industry on proposed action levels for lead in foods consumed by babies and children under the age of two.” The lawmakers further call for the agency to expedite its Phase 2 and Phase 3 commitments of the Closer to Zero plan, and to provide responses to the following inquiries by February 20, 2023: When will FDA finalize action levels for lead in juices and processed baby foods? When does FDA expect to release draft guidance on arsenic levels in foods consumed by babies and children under the age of two? When does FDA expect to submit draft guidance on mercury levels in all foods intended for babies and children under the age of two? What steps will FDA take in the interim to address the high levels of toxic heavy metals found in the baby foods tested in the recent reports? The letter was spurred by a recent investigative report published by Bloomberg Law (subscription required), where researchers conducted independent testing of 33 baby food products purchased in July 2022, and found that all but one tested positive for at least two toxic heavy metals. Tags: Arsenic, Baby Food, Cadmium, Congress, Heavy Metals, Lead, Mercury More Baby Food Lawsuit Stories Motion To Dismiss Toxic Baby Food Lawsuit Master Complaint To Be Filed Next Month May 28, 2025 Judge Sets Deadline for Toxic Baby Food Lawsuits To Be Directly Filed in MDL May 2, 2025 Baby Food Toxic Metal Lawsuits Cleared To Move Forward by Federal Judge April 8, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)